Sanofi
SNY
#175
Rank
NZ$202.55 B
Marketcap
NZ$82.98
Share price
0.90%
Change (1 day)
5.60%
Change (1 year)

Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthรฉlabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.

Market capitalization of Sanofi (SNY)

Market cap: NZ$202.55 Billion

As of December 2025 Sanofi has a market cap of NZ$202.55 Billion. This makes Sanofi the world's 175th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sanofi from 2002 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$202.55 B-6.5%
2024NZ$216.63 B9.85%
2023NZ$197.20 B3.08%
2022NZ$191.31 B4.03%
2021NZ$183.91 B9.12%
2020NZ$168.54 B-9.82%
2019NZ$186.89 B16.3%
2018NZ$160.69 B5.73%
2017NZ$151.98 B0.62%
2016NZ$151.05 B-7.86%
2015NZ$163.93 B5.82%
2014NZ$154.92 B-9.73%
2013NZ$171.62 B11.52%
2012NZ$153.89 B21%
2011NZ$127.18 B17.61%
2010NZ$108.14 B-24.48%
2009NZ$143.20 B-1.73%
2008NZ$145.72 B-10.26%
2007NZ$162.37 B-8.87%
2006NZ$178.18 B-1.01%
2005NZ$180.00 B13.61%
2004NZ$158.43 B86.14%
2003NZ$85.11 B0.04%
2002NZ$85.08 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Sanofi was reported to be:

NZ$201.95 Billion
by Nasdaq info icon info icon
NZ$200.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
NZ$419.27 B 106.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$252.04 B 24.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$179.25 B-11.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$432.84 B 113.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$168.14 B-16.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$58.78 B-70.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
NZ$855.65 B 322.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.531 T 656.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$374.76 B 85.02%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Abbott Laboratories
ABT
NZ$366.75 B 81.07%๐Ÿ‡บ๐Ÿ‡ธ USA